Proteomic analysis of autoantibodies in neuropsychiatric systemic lupus erythematosus patient with white matter hyperintensities on brain MRI

Lupus

Volumn 17, Issue 1, 2008, Pages 16-20

  Kimura, Akio ^a   Sakurai, T ^a   Tanaka, Y ^a   Hozumi, I ^a   Takahashi, K ^a   Takemura, M ^a   Saito, K ^a   Seishima, M ^a   Inuzuka, T ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

60 kDa heat shock protein (Hsp60); Endothelial cell; Neuropsychiatric systemic lupus erythematosus (NPSLE); Proteome; White matter hyperintensity (WMH)

Indexed keywords

ALPHA INTERNEXIN; AUTOANTIBODY; BETA ACTIN; ENDOTHELIAL CELL ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; HEAT SHOCK PROTEIN 60;

AGED; ANTIBODY DETECTION; ARTICLE; BRAIN DAMAGE; CASE REPORT; CEREBELLUM; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; MIDDLE CEREBELLAR PEDUNCLE; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEOMICS; SYSTEMIC LUPUS ERYTHEMATOSUS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; WHITE MATTER;

ACTINS; AGED; ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; BRAIN; CHAPERONIN 60; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; PROTEOMICS; RATS; TANDEM MASS SPECTROMETRY;

EID: 41749105515     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307085112     Document Type: Article

References (24)

1. Bell CL, Partington C, Robbins M, Graziano F, Turski P, Kornguth S. Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers. Arthritis Rheum 1991; 34: 432-441.
2. Sanna G, Piga M, Terryberry JW et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus 2000; 9: 573-583.
3. Hachulla E, Michon-Pasturel U, Leys D et al. Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies. Lupus 1998; 7: 124-131.
4. Markus HS, Hunt B, Palmer K, Enzinger C, Schmidt H, Schmidt R. Markers of endothelial and hemostatic activation and progression of cerebral white matter hyperintensities. Longitudinal results of the Austrian stroke prevention study. Stroke 2005; 36: 1410-1414.
5. Gunning-Dixon FM, Raz N. The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. Neuropsychology 2000; 14: 224-232.
6. Sachdev PS, Wen W, Christensen H, Jorm AF. White matter hyperintensities are related to physical disability and poor motor function. J Neurol Neurosurg Psychiatry 2005; 76: 362-367.
7. Mosley TH, Knopman DS, Catelier DJ et al. Cerebral MRI findings and cognitive functioning. The atherosclerosis risk in communities study. Neurology 2005; 64: 2056-2062.
8. ACR Ad Hoc Committee On Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
9. Hochbreg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
10. Bluestein HG, Zvaifler NJ. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest 1976; 57: 509-516.
11. Bonfa E, Golombek SJ, Kaufman LD et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med 1987; 317: 265-271.
12. Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
13. Song J, Park YB, Lee WK, Lee KH, Lee SK. Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000; 20: 1-7.
14. Meroni PL, Tincani A, Sepp N et al. Endothelium and the brain in CNS lupus. Lupus 2003; 12: 919-928.
15. Dieudé M, Senécal JL, Raymond Y. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients. Arthritis Rheum 2004; 50: 3221-3231.
16. Martin J, Horwich AL, Hartl FU. Prevention of protein denaturation under heat stress by the chaperonin Hsp60. Science 1992; 258: 995-998.
17. Jamin C, Dugué C, Alard JE et al. Induction of endothelial cell apoptosis by the binding of anti-endothelial cell antibodies to Hsp60 in vasculitis-associated systemic autoimmune diseases. Arthritis Rheum 2005; 52: 4028-4038.
18. Schett G, Xu Q, Amberger A et al. Autoantibodies against HSP60 mediate endothelial cytotoxicity. J Clin Invest 1995; 96: 2569-2577.
19. Zhu J, Katz RJ, Quyyumi AA et al. Antibodies to HSP60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001; 103: 1071-1075.
20. Bason C, Corrocher R, Lunardi C et al. Interaction of antibodies against cytomegalovirus with heat-shock protein 60 in pathogenesis of atherosclerosis. Lancet 2003; 362: 1971-1977.
21. Trysberg E, Nylen K, Rosengren LE, Tarkowski A. Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement. Arthritis Rheum 2003; 48: 2881-2887.
22. Valesini G, Alessandri C, Celestino D, Conti F. Anti-endothelial antibodies and neuropshychiatric systemic lupus erythematosus. Ann NY Acad Sci 2006; 1069: 118-128.
23. Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M. Identification of beta-actin as a candidate autoantigen in autoimmune inner ear disease. Clin Otolaryngol 2000; 25: 535-541.
24. Rajasalu T, Teesalu K, Janmey PA, Uibo R. Demonstration of natural autoantibodies against the neurofilament protein α-internexin in sera of patients with endocrine autoimmunity and healthy individuals. Immunol Lett 2004; 94: 153-160.